@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
ns1:result .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T20:04:34.726291"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "in inhibition of spike glycoprotein S1-induced NF-κB activation" .
rdf:OBJECT-POSITION rdfs:label "173"^^xsd:integer .
rdf:PREDICATE rdfs:label "resulted" .
rdf:PREDICATE-POSITION rdfs:label "[111]" .
rdf:SUBJECT rdfs:label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" .
rdf:SUBJECT-POSITION rdfs:label "12"^^xsd:integer .
rdfs:ABSTRACT-UID ns3:50 "z9oyrkzt" .
rdfs:SENTENCE rdfs:label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." .
rdfs:TRIPLE-UID ns2:z9oyrkzt-TRIPLE-ABSTRACT-2 "z9oyrkzt-TRIPLE-ABSTRACT-2" .
rdfs:label "human" .
rdfs:label "activation" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "O/oVhN5cxLscMNI9dDseZgv+BC7ibwIsND6vTNpDo6PBM6axZCzE71G5aoJzTYgWfUkhRvTcO5A3Jx/fOvwv2MlXCVt9cGd9hnKCzund5Jm+gzdkL/xAi6X9KGk3eIjw7dc8jkSKHVmgJ3/Zwt6e7pkek+SPIyyfYAWh67ZWxNs=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T20:04:34.726291"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}